Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
153.11
+0.11 (0.07%)
Nov 20, 2024, 4:00 PM EST - Market closed
Johnson & Johnson Employees
Johnson & Johnson had 131,900 employees as of December 31, 2023. The number of employees decreased by 20,800 or -13.62% compared to the previous year.
Employees
131,900
Change (1Y)
-20,800
Growth (1Y)
-13.62%
Revenue / Employee
$664,867
Profits / Employee
$111,327
Market Cap
368.63B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 131,900 | -20,800 | -13.62% |
Dec 31, 2022 | 152,700 | 11,000 | 7.76% |
Dec 31, 2021 | 141,700 | 7,200 | 5.35% |
Dec 31, 2020 | 134,500 | 2,300 | 1.74% |
Dec 29, 2019 | 132,200 | -2,900 | -2.15% |
Dec 30, 2018 | 135,100 | 1,100 | 0.82% |
Dec 31, 2017 | 134,000 | 7,600 | 6.01% |
Dec 31, 2016 | 126,400 | -700 | -0.55% |
Dec 31, 2015 | 127,100 | 600 | 0.47% |
Dec 28, 2014 | 126,500 | -1,600 | -1.25% |
Dec 29, 2013 | 128,100 | 500 | 0.39% |
Dec 30, 2012 | 127,600 | 9,700 | 8.23% |
Dec 31, 2011 | 117,900 | 3,900 | 3.42% |
Dec 31, 2010 | 114,000 | -1,500 | -1.30% |
Dec 31, 2009 | 115,500 | -3,200 | -2.70% |
Dec 28, 2008 | 118,700 | -500 | -0.42% |
Dec 30, 2007 | 119,200 | -3,000 | -2.45% |
Dec 31, 2006 | 122,200 | 6,600 | 5.71% |
Dec 31, 2005 | 115,600 | 5,600 | 5.09% |
Dec 31, 2004 | 110,000 | -1,000 | -0.90% |
Dec 28, 2003 | 111,000 | 3,000 | 2.78% |
Dec 29, 2002 | 108,000 | 6,000 | 5.88% |
Dec 30, 2001 | 102,000 | 1,000 | 0.99% |
Dec 31, 2000 | 101,000 | 3,200 | 3.27% |
Dec 31, 2000 | 97,800 | 4,700 | 5.05% |
Dec 31, 1999 | 93,100 | 2,600 | 2.87% |
Dec 28, 1997 | 90,500 | 1,200 | 1.34% |
Dec 29, 1996 | 89,300 | 7,000 | 8.51% |
Dec 31, 1995 | 82,300 | 800 | 0.98% |
Dec 31, 1995 | 81,500 | -100 | -0.12% |
Dec 31, 1994 | 81,600 | -3,300 | -3.89% |
Dec 31, 1993 | 84,900 | 2,200 | 2.66% |
Dec 31, 1991 | 82,700 | 500 | 0.61% |
Dec 31, 1990 | 82,200 | -900 | -1.08% |
Dec 31, 1989 | 83,100 | 1,800 | 2.21% |
Dec 31, 1988 | 81,300 | 3,100 | 3.96% |
Dec 31, 1987 | 78,200 | 1,100 | 1.43% |
Dec 31, 1986 | 77,100 | 2,200 | 2.94% |
Dec 31, 1985 | 74,900 | 700 | 0.94% |
Dec 31, 1984 | 74,200 | -3,200 | -4.13% |
Dec 31, 1983 | 77,400 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
AbbVie | 50,000 |
JNJ News
- 53 minutes ago - Which Is A Better Pick: JNJ Stock Or AbbVie? - Forbes
- 16 hours ago - Of 63 Fortune 500 Industry Leaders, 57 Pay Dividends, 38 Are Cash Rich And 1 Is A Buy - Seeking Alpha
- 1 day ago - If I Could Only Buy 2 High Dividend Yield Companies In November 2024: Both Yield Above 6% - Seeking Alpha
- 1 day ago - Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive - Seeking Alpha
- 1 day ago - Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting - PRNewsWire
- 2 days ago - J&J's skin disease drug meets main goals of late-stage study - Reuters
- 2 days ago - Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results - PRNewsWire
- 2 days ago - Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of Icotrokinra (JNJ-2113) in Plaque Psoriasis, a First-in-Class Investigational Targeted Oral Peptide That Selectively Blocks the IL-23 Receptor - Accesswire